Enhanced Recovery After Surgery (ERAS) in Live Donor Kidney Transplant Recipients
NCT ID: NCT06997016
Last Updated: 2026-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
PHASE4
60 participants
INTERVENTIONAL
2025-05-05
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does the ERAS protocol lower the amount of opioid narcotic medication needed to manage post-surgery pain? Does the ERAS protocol help lower pain scores after surgery? Researchers will compare the ERAS protocol to previous patients where the ERAS protocol was not used to see if the ERAS protocol works to reduce post-surgery pain.
Participants will be asked to:
* Drink a pre-surgery carbohydrate drink two hours before your surgery.
* Take a pre-surgery dose of Tylenol by mouth.
* Take a pre-surgery dose of Gabapentin by mouth.
* The surgeon will administer a local numbing medication at the surgery site by injection during the surgery.
* Begin walking with assistance about 12 hours after your surgery.
* Allow the research staff to collect data about your kidney function. This data will be collected on your postoperative clinic visits, which generally occur about twice weekly for one month. This information will determine your kidney health, need for hospitalization, and side effects that may occur.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-opioid Based Pain Control After Thyroidectomy
NCT03988075
Postoperative Pain Protocol Limiting Narcotics for Laparoscopic Hand-assisted Donor Nephrectomy
NCT06458842
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
NCT05722002
Postoperative Analgesia After Total Knee Arthroplasty
NCT00421967
Enhanced Recovery Strategies in Elective Breast Surgery
NCT03187080
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Enhanced Recovery Protocol
This group will receive the following:
50g carbohydrate drink 2 hours prior to surgery 300mg of gabapentin 30 minutes prior to surgery 650mg of acetaminophen 30 minutes prior to surgery 0.25% bupivicaine local anesthetic intraoperatively assisted ambulation 12 hours after surgery
pre-operative carbohydrate drink
50 g of carbohydrate drink 2 hours before surgery
Acetaminophen
650mg acetaminophen 30 minutes prior to surgery
Gabapentin
300 mg gabapentin 30 minutes prior to surgery
Bupivacaine
intraoperative local anesthetic
Ambulation
Assisted ambulation 12 hours after surgery
Control group
This group is a retrospective review of 30 patients who have undergone a live donor kidney transplant during 1/1/2022-12/31/2024 will be selected and undergo a retrospective chart review for the same data collection points.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pre-operative carbohydrate drink
50 g of carbohydrate drink 2 hours before surgery
Acetaminophen
650mg acetaminophen 30 minutes prior to surgery
Gabapentin
300 mg gabapentin 30 minutes prior to surgery
Bupivacaine
intraoperative local anesthetic
Ambulation
Assisted ambulation 12 hours after surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* over 18 years of age
* receiving a kidney transplant from a living donor.
Exclusion Criteria
* severe type I diabetes
* allergy to interventional medications
* pregnancy (this is a normal exclusion for kidney recipients)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baylor Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Ruiz, MD
Role: PRINCIPAL_INVESTIGATOR
Baylor Scott & White All Saints Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baylor Scott & White All Saints Medical Center
Fort Worth, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Baylor IRB #025-220
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.